The utility and feasibility of assessing sleep disruption in a men's health clinic using a mobile health platform device: A pilot study

Hai H. Le, Rachel Salas, Alyssa Gamaldo, Kevin Lenuell Billups, Peter Dziedzic, Seulah Choi, Neftali Bermudez, Roland J Thorpe, Charlene Gamaldo

Research output: Contribution to journalArticle

Abstract

Introduction: Evidence linking sleep disruption and sexual dysfunction in men is mounting; yet the characterisation of sleep patterns and complaints utilising a clinically feasible method within this patient population remain largely under-reported. Aim: A pilot study aiming to demonstrate a clinically feasible method to characterise the sleep patterns and complaints in a representative sample of patients treated in a men's health clinic. Methods: Male patients (n = 48) completed a battery of validated sleep questionnaires using an mHealth mobile platform, MySleepScript, at the Johns Hopkins Men's Health and Vitality Center. Metrics related to clinical feasibility such as completion time, ease of use, preference of electronic format, and patient satisfaction were also collected. Main Outcome Measures: Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Berlin Questionnaire, Patient Health Questionnaire (PHQ-9), and Primary Care PTSD Screen (PC-PTSD). Results: Primary urological chief symptoms for this sample patient population were erectile dysfunction (ED; 80%), hypogonadism (40%), benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS; 40%) and Peyronie's disease (10%). Mean PSQI score was 7.8 [SD 4.2], with 67% of all patients falling within the "poor sleeper" range. At least mild symptoms of depression were noted in 40% and 43% were at risk for obstructive sleep apnea (OSA) on the Berlin Questionnaire. Conclusions: This pilot study demonstrated the feasibility and potential utility of an mHealth platform to assist clinicians, within a men's health clinic, in detecting sleep disturbances. Disrupted sleep was revealed in well over half of this sample of patients. As a result of the growing evidence linking poor sleep and sleep disorders (eg, OSA) to the conditions relevant to men's health (eg, erectile dysfunction, hypogonadism and BPH), further efforts beyond this pilot study are necessary to identify the aetiological processes underlying the association between specific disrupted sleep disorders and urological conditions.

Original languageEnglish (US)
JournalInternational Journal of Clinical Practice
DOIs
StateAccepted/In press - 2017

Fingerprint

Men's Health
Telemedicine
Sleep
Equipment and Supplies
Hypogonadism
Berlin
Obstructive Sleep Apnea
Erectile Dysfunction
Penile Induration
Patient Advocacy
Lower Urinary Tract Symptoms
Prostatic Hyperplasia
Sleep Initiation and Maintenance Disorders
Post-Traumatic Stress Disorders
Patient Satisfaction
Population
Primary Health Care
Outcome Assessment (Health Care)
Depression

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{5d985e6c9911426babc3ab0e27b8c9fc,
title = "The utility and feasibility of assessing sleep disruption in a men's health clinic using a mobile health platform device: A pilot study",
abstract = "Introduction: Evidence linking sleep disruption and sexual dysfunction in men is mounting; yet the characterisation of sleep patterns and complaints utilising a clinically feasible method within this patient population remain largely under-reported. Aim: A pilot study aiming to demonstrate a clinically feasible method to characterise the sleep patterns and complaints in a representative sample of patients treated in a men's health clinic. Methods: Male patients (n = 48) completed a battery of validated sleep questionnaires using an mHealth mobile platform, MySleepScript, at the Johns Hopkins Men's Health and Vitality Center. Metrics related to clinical feasibility such as completion time, ease of use, preference of electronic format, and patient satisfaction were also collected. Main Outcome Measures: Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Berlin Questionnaire, Patient Health Questionnaire (PHQ-9), and Primary Care PTSD Screen (PC-PTSD). Results: Primary urological chief symptoms for this sample patient population were erectile dysfunction (ED; 80{\%}), hypogonadism (40{\%}), benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS; 40{\%}) and Peyronie's disease (10{\%}). Mean PSQI score was 7.8 [SD 4.2], with 67{\%} of all patients falling within the {"}poor sleeper{"} range. At least mild symptoms of depression were noted in 40{\%} and 43{\%} were at risk for obstructive sleep apnea (OSA) on the Berlin Questionnaire. Conclusions: This pilot study demonstrated the feasibility and potential utility of an mHealth platform to assist clinicians, within a men's health clinic, in detecting sleep disturbances. Disrupted sleep was revealed in well over half of this sample of patients. As a result of the growing evidence linking poor sleep and sleep disorders (eg, OSA) to the conditions relevant to men's health (eg, erectile dysfunction, hypogonadism and BPH), further efforts beyond this pilot study are necessary to identify the aetiological processes underlying the association between specific disrupted sleep disorders and urological conditions.",
author = "Le, {Hai H.} and Rachel Salas and Alyssa Gamaldo and Billups, {Kevin Lenuell} and Peter Dziedzic and Seulah Choi and Neftali Bermudez and Thorpe, {Roland J} and Charlene Gamaldo",
year = "2017",
doi = "10.1111/ijcp.12999",
language = "English (US)",
journal = "International Journal of Clinical Practice",
issn = "1368-5031",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The utility and feasibility of assessing sleep disruption in a men's health clinic using a mobile health platform device

T2 - A pilot study

AU - Le, Hai H.

AU - Salas, Rachel

AU - Gamaldo, Alyssa

AU - Billups, Kevin Lenuell

AU - Dziedzic, Peter

AU - Choi, Seulah

AU - Bermudez, Neftali

AU - Thorpe, Roland J

AU - Gamaldo, Charlene

PY - 2017

Y1 - 2017

N2 - Introduction: Evidence linking sleep disruption and sexual dysfunction in men is mounting; yet the characterisation of sleep patterns and complaints utilising a clinically feasible method within this patient population remain largely under-reported. Aim: A pilot study aiming to demonstrate a clinically feasible method to characterise the sleep patterns and complaints in a representative sample of patients treated in a men's health clinic. Methods: Male patients (n = 48) completed a battery of validated sleep questionnaires using an mHealth mobile platform, MySleepScript, at the Johns Hopkins Men's Health and Vitality Center. Metrics related to clinical feasibility such as completion time, ease of use, preference of electronic format, and patient satisfaction were also collected. Main Outcome Measures: Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Berlin Questionnaire, Patient Health Questionnaire (PHQ-9), and Primary Care PTSD Screen (PC-PTSD). Results: Primary urological chief symptoms for this sample patient population were erectile dysfunction (ED; 80%), hypogonadism (40%), benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS; 40%) and Peyronie's disease (10%). Mean PSQI score was 7.8 [SD 4.2], with 67% of all patients falling within the "poor sleeper" range. At least mild symptoms of depression were noted in 40% and 43% were at risk for obstructive sleep apnea (OSA) on the Berlin Questionnaire. Conclusions: This pilot study demonstrated the feasibility and potential utility of an mHealth platform to assist clinicians, within a men's health clinic, in detecting sleep disturbances. Disrupted sleep was revealed in well over half of this sample of patients. As a result of the growing evidence linking poor sleep and sleep disorders (eg, OSA) to the conditions relevant to men's health (eg, erectile dysfunction, hypogonadism and BPH), further efforts beyond this pilot study are necessary to identify the aetiological processes underlying the association between specific disrupted sleep disorders and urological conditions.

AB - Introduction: Evidence linking sleep disruption and sexual dysfunction in men is mounting; yet the characterisation of sleep patterns and complaints utilising a clinically feasible method within this patient population remain largely under-reported. Aim: A pilot study aiming to demonstrate a clinically feasible method to characterise the sleep patterns and complaints in a representative sample of patients treated in a men's health clinic. Methods: Male patients (n = 48) completed a battery of validated sleep questionnaires using an mHealth mobile platform, MySleepScript, at the Johns Hopkins Men's Health and Vitality Center. Metrics related to clinical feasibility such as completion time, ease of use, preference of electronic format, and patient satisfaction were also collected. Main Outcome Measures: Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Berlin Questionnaire, Patient Health Questionnaire (PHQ-9), and Primary Care PTSD Screen (PC-PTSD). Results: Primary urological chief symptoms for this sample patient population were erectile dysfunction (ED; 80%), hypogonadism (40%), benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS; 40%) and Peyronie's disease (10%). Mean PSQI score was 7.8 [SD 4.2], with 67% of all patients falling within the "poor sleeper" range. At least mild symptoms of depression were noted in 40% and 43% were at risk for obstructive sleep apnea (OSA) on the Berlin Questionnaire. Conclusions: This pilot study demonstrated the feasibility and potential utility of an mHealth platform to assist clinicians, within a men's health clinic, in detecting sleep disturbances. Disrupted sleep was revealed in well over half of this sample of patients. As a result of the growing evidence linking poor sleep and sleep disorders (eg, OSA) to the conditions relevant to men's health (eg, erectile dysfunction, hypogonadism and BPH), further efforts beyond this pilot study are necessary to identify the aetiological processes underlying the association between specific disrupted sleep disorders and urological conditions.

UR - http://www.scopus.com/inward/record.url?scp=85028845961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028845961&partnerID=8YFLogxK

U2 - 10.1111/ijcp.12999

DO - 10.1111/ijcp.12999

M3 - Article

C2 - 28869721

AN - SCOPUS:85028845961

JO - International Journal of Clinical Practice

JF - International Journal of Clinical Practice

SN - 1368-5031

ER -